temperature is not reported; however, doping of copper with molybdenum metal has been realized here to be more efficient for C-S cross-coupling in comparison to general CuII catalyst. The doped catalyst CuMoO4 nanoparticle is found to be more efficient than copper. The catalyst works under mild conditions without any ligand at room temperature and is recyclable and effective for a wide range of thiols and
(Aryloxy)aryl Semicarbazones and Related Compounds: A Novel Class of Anticonvulsant Agents Possessing High Activity in the Maximal Electroshock Screen
作者:Jonathan R. Dimmock、Ramanan N. Puthucode、Jennifer M. Smith、Mark Hetherington、J. Wilson Quail、Uma Pugazhenthi、Terry Lechler、James P. Stables
DOI:10.1021/jm9603025
日期:1996.1.1
A number of (aryloxy)arylsemicarbazones and related compounds were synthesized and evaluated for anticonvulsant activities. After intraperitoneal injection to mice, the semicarbazones were examined in the maximal electroshock (MES), subcutaneous pentylenetetrazole (scPTZ), and neurotoxicity (NT) screens. The results indicated that greater protection was obtained in the MES test than the scPTZ screen
GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
申请人:AbbVie Inc.
公开号:EP3901162A1
公开(公告)日:2021-10-27
Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
Glucocorticoid receptor agonist and immunoconjugates thereof
申请人:AbbVie Inc.
公开号:US10668167B2
公开(公告)日:2020-06-02
Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
disclosed new bimetallic BaMoO4 nanoparticles for the C–Scross-couplingreaction. The C–Scross-couplingreaction of alkyl/aryl thiols with haloarenes was accomplished with high yields. The reaction has good functional group tolerance and selectivity. This is an efficient protocol for synthesizing the building blocks of pharmaceuticals containing C–S bonds. The catalyst is recyclable. The unactivated